Edwin Kania, Director at TransMedics Group, holds 309.87K shares in TransMedics Group (Ticker: TMDX), holds 23.85K shares in Moderna (Ticker: MRNA), holds 572.79K shares in Acceleron Pharma (Ticker: XLRN).
Edwin Kania latest transaction was an Uninformative Buy of ―.
What was Edwin Kania's most profitable transaction?
Edwin Kania’s most profitable transaction was an Informative Buy of TMDX stock on November 30, 2021. The return on the trade was 180.70%.
What is Edwin Kania's role in TransMedics Group?
Edwin Kania's role in TransMedics Group is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.